SYNCONA IP HOLDCO (2) LIMITED
Company number 14312542 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1
Balance sheet as at 2023-03-31
What it does
Syncona IP Holdco (2) Limited (the "Company") is a private company limited by shares registered in England and Wales. The company was incorporated on 23 August 2022. The company's principal activity during the period is the licencing of intellectual property relating to Healthcare treatments and technologies. It is anticipated that in the forthcoming year the Company will continue to hold, as well as licence, Intellectual Property.On 24 March 2023 the Company purchased a license from Freeline Therapeutics Limited for up front consideration of £500,000 to use Patents PCT/GB2022/052787, PCT/GB2021/051627, PCT/GB2022/052792 and immediately sublicensed this to Beacon Therapeutics Limited (formerly Alliance Holdco Limited) for upfront consideration of £500,000. Freeline Therapeutics Holdings Limited and Beacon Therapeutics Limited are affiliates of Syncona Limited, the Ultimate Parent Company of the Company.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2022-08-23
- Employees
- 0 (2023 accounts)
- Registered office
- 8 Bloomsbury Street, London, England, WC1B 3SR
- Postcode
- WC1B 3SR
- Accounts category
- Full
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2025-08-22
- Next due by
- 2026-09-05
Nature of business (SIC)
- 64209 Activities of other holding companies not elsewhere classified
Officers 2 current · 3 resigned
Group structure
Controlled by Syncona Limited (00055514) — since 2022-08-23
From persons-with-significant-control filings on the public register.
Competitors London
This company ranks 938 among activities of other holding companies not elsewhere classified in London.